Atlas Trials

Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73

Clinical trial NCT06995976 · RECRUITING

Trial details

NCT number
NCT06995976
Sponsor
First Affiliated Hospital of Fujian Medical University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Malignant Tumour
Start date
2025-03-01
Primary completion
2025-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.